Iona Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.50 M
as on 14-12-2024
- Company Age 9 Year, 18 Days
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2019)
- Profit 160.90%
(FY 2019)
- Ebitda 160.90%
(FY 2019)
- Net Worth 32.38%
(FY 2019)
- Total Assets 1820.48%
(FY 2019)
About Iona Pharmatech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sujatha Tanniru, Krutika Misra, and Vijay Bandla serve as directors at the Company.
- CIN/LLPIN
U74120TG2015PTC102307
- Company No.
102307
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2015
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Iona Pharmatech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujatha Tanniru  | Director | 18-Dec-2015 | Current |
| Krutika Misra | Director | 18-Dec-2015 | Current |
| Vijay Bandla | Director | 18-Dec-2015 | Current |
Financial Performance of Iona Pharmatech.
Iona Pharmatech Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 160.9% increase in profit. The company's net worth Soared by an impressive increase of 32.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iona Pharmatech?
In 2019, Iona Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Inavir Pharmatech Private LimitedActive 13 years 5 monthsSujatha Tanniru, Krutika Misra and 1 more are mutual person
Vidur Human Care Private LimitedActive 6 years 9 monthsSujatha Tanniru and Vijay Bandla are mutual person
- Hakue Labs Private LimitedActive 18 years 8 months
Sujatha Tanniru and Vijay Bandla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Iona Pharmatech?
Unlock and access historical data on people associated with Iona Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iona Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iona Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
